ANDA 70783, held by Par Pharm. Chlorothiazide; Methyldopa.
As of Nov 15, 2026, ANDA 70783 (Methyldopa And Chlorothiazide), held by Par Pharm, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Methyldopa And Chlorothiazide150MG;250MG ยท tablet;oral | Chlorothiazide; Methyldopa | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
